FDA signs research agreement to build drug safety analysis platform

To improve the speed and quality of analysis of drug safety analysis, the Food and Drug Administration is partnering with Commonwealth Informatics to make it easier for its reviewers detect and investigate safety signals during new drug application reviews and post-market drug monitoring.

Read more: gcn.com